Ethyl Acetate → (3aR)-Tetrahydro-1H,3H-1lambda~6~-pyrrolo[1,2-c][1,2,3]oxathiazole-1,1-dione

The (R)-1-oxo-3a,4,5,6-tetrahydropyrrolo[1,2-c][1,2,3]oxathiazolidine, from the previous step, and 20 mL ethyl acetate were added to a 50 mL round bottom flask equipped with a magnetic stirrer. A catalytic amount of RuCl3.3H2O (a few mg) was added, followed by NaIO4 (3.17 g; 14.82 mmol) in 10 mL water. The mixture was stirred vigorously for one hour. The phases were separated, and the aqueous phase was extracted with three portions (10 mL each) ethyl acetate. The combined organic phases were washed with 10 mL aqueous sodium thiosulfate, 10 mL half-saturated brine, and 10 mL brine, and then dried over MgSO4. The solvent was removed on a rotary evaporator with a 40° C. water bath to yield 0.65 g (3.98 mmol) of (R)-1,1-dioxo-3a,4,5,6-tetrahydropyrrolo[1,2-c][1,2,3]oxathiazolidine as a colorless oil which crystallized spontaneously.

1. customequipped with a magnetic stirrer
2. customThe phases were separated
3. extractionthe aqueous phase was extracted with three portions (10 mL each) ethyl acetate
4. washThe combined organic phases were washed with 10 mL aqueous sodium thiosulfate, 10 mL half-saturated brine, and 10 mL brine
5. dry with materialdried over MgSO4
6. customThe solvent was removed on a rotary evaporator with a 40° C. water bath

ORD record

ord-1c41d10b0bcc429ba75fbbde4d74ea92

Source dataset

uspto-grants-1992_07

DOI

10.6084/m9.figshare.5104873.v1

Patent number

US05130432